Zanamivir for Inhalation (Relenza)

The Defense Logistics Agency Troop Support is soliciting proposals for the supply of Zanamivir for Inhalation.  

A Firm Fixed Price Requirements contract is proposed with a one-year Base Period. All DoD requirements will be placed on the proposed contract. The estimated quantity for the Base Period is 175,000 EA.

Delivery is to be FOB Destination and delivered within 200 days from date of the delivery order. Contractor is required to deliver to various Contiguous United States (CONUS) locations provided at the time of the delivery order.

All responsible sources may submit a proposal and shall be considered by the Agency.

The successful contractor shall have Food and Drug Administration (FDA) approval to sell Zanamivir for Inhalation before award of the contract.

Solicitation SPE2DP-21-R-0002 is expected to be issued on or around May 4, 2022 and can be found on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. The point of contact is Amanda Doherty, DLA Troop Support - FSA, 215-737-9508.

The Solicitation will be issued under authority 10 U.S.C. 2034 (c) 1, only one responsible source.

Place of Performance:

Contracting Office Address:

700 Robbins Avenue
Philadelphia, Pennsylvania 19111-5092
United States

Primary Point of Contact:

Amanda Doherty

Contracting Officer

Amanda.doherty@dla.mil

Phone: 215-737-9508